Mucipoly P 75 Tablet: A High-Demand Respiratory Product for Your PCD Pharma Franchise

The Consistent Market for Respiratory Care Medications

Understanding the Synergistic Action of Acetylcysteine and Pyridoxamine

Why Mucipoly P 75 is the Ideal Choice for Your B2B Pharma Portfolio

Quality, Efficacy, and Our Commitment to Your Success
How to Begin Your Monopoly Franchise in Respiratory Care

Home/Products /acetylcysteine-300mg-pyridoxamine-dihydrochloride-75mg-table

About the Product

Description


In the critical and consistently high-demand field of respiratory health, products that offer both efficacy and added benefits are essential. Mucipoly P 75 Tablet, a powerful combination of Acetylcysteine (300mg) and Pyridoxamine dihydrochloride (75mg), is a best-in-class product for the management of respiratory conditions. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.

Acetylcysteine is a well-established mucolytic agent that works by thinning and loosening mucus in the airways, making it easier to clear. This provides significant relief for patients with conditions like chronic bronchitis and cystic fibrosis. The addition of Pyridoxamine dihydrochloride, a powerful antioxidant, helps to mitigate oxidative stress, a key factor in many chronic diseases. This unique dual-action formula makes Mucipoly P 75 Tablet a highly trusted and effective option for healthcare professionals.

At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Mucipoly P 75 Tablet is manufactured in state-of-the-art facilities with strict quality controls. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the respiratory segment.

Common side effects may include thirst, dry mouth, increased urination, dizziness, and weakness. Some patients may develop hypernatremia (elevated blood sodium), low blood pressure, or mild liver enzyme elevations. Rare but serious side effects include severe dehydration, kidney dysfunction, or allergic reactions. Patients experiencing severe or persistent symptoms should seek medical attention promptly.

Tolvise 30 Tablet is indicated for the treatment of hyponatremia (low blood sodium levels), particularly in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH), heart failure, or cirrhosis. Tolvaptan selectively blocks vasopressin V2 receptors in the kidneys, promoting excretion of free water while preserving essential electrolytes. This mechanism helps restore normal sodium levels, reduce fluid overload, and relieve symptoms such as edema, fatigue, and breathlessness, thereby improving overall fluid balance and patient well-being.

Tolvise 30 Tablet should be taken exactly as prescribed by a healthcare professional, usually once daily, with close monitoring of blood sodium levels. Excessive fluid intake should be avoided unless specifically advised by the physician. Caution is recommended in patients with liver impairment, kidney dysfunction, or low blood pressure. The medication should not be stopped abruptly without medical supervision, as sudden discontinuation may cause imbalances in sodium and fluid levels.

Store Tolvise 30 Tablet in a cool, dry place, below 25°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of the reach of children. Do not use the tablets beyond the expiry date indicated on the label.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Acetylcysteine 300mg + Pyridoxamine Dihydrochloride 75mg Tablet in the PCD pharma franchise market?

This combination has strong demand in the hepatology, antioxidant, and metabolic support segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on liver health and oxidative stress management portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from demand in liver protection and metabolic support therapies. Acetylcysteine 300mg works as a mucolytic and antioxidant, while Pyridoxamine (a vitamin B6 derivative) supports amino acid metabolism and helps reduce glycation-related oxidative stress, strengthening a comprehensive liver and metabolic care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this combination tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady hepatoprotective prescription demand, growing lifestyle disease management market, reliable supply chain support, and good margins when partnering for this combination product.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, and wholesalers interested in this combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.